BackMedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview
MedTech Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Debt to Equity

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) has a debt-to-equity ratio of 5.26, above the sector sector average of 0.2.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

5.26

Debt to Equity

5.26

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) FAQ

As of the most recent data, MTACU shows a debt-to-equity ratio of 5.26. That is above the sector sector average of 0.2. Scroll down for historical charts and peer comparison views.

The its sector sector average debt-to-equity ratio is about 0.2. MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) is at 5.26, which is higher that average. That is roughly 2518.1% above the sector mean. Use the comparison chart on this page to see how MTACU stacks up against individual peers as well.

Investors watch MTACU's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s latest reading is 5.26. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 5.26) with ownership activity and broader fundamentals.